Cited by 312Influenza Virus Research StudiesImmune responses and vaccinationsRespiratory viral infections research

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies

Open access

Sasaki, Sanae, Sullivan, Meghan, Narvaez, Carlos F., Holmes, Tyson H., Furman, David, Zheng, Nai-Ying, Nishtala, Madhuri, Wrammert, Jens, Smith, Kenneth, James, Judith A., Dekker, Cornelia L., Davis, Mark M., Wilson, Patrick C., Greenberg, Harry B., He, Xiao-Song·2011·Journal of Clinical Investigation

DOI 10.1172/jci57834PMC PMC3148747

Open this paper in CoChat — free account Open PDF

Abstract

During seasonal influenza epidemics, disease burden is shouldered predominantly by the very young and the elderly. Elderly individuals are particularly affected, in part because vaccine efficacy wanes with age. This has been linked to a reduced ability to induce a robust serum antibody response. Here, we show that this is due to reduced quantities of vaccine-specific antibodies, rather than a lack of antibody avidity or affinity. We measured levels of vaccine-specific plasmablasts by ELISPOT 1 week after immunization of young and elderly adults with inactivated seasonal influenza vaccine. Plasmablast-derived polyclonal antibodies (PPAbs) were generated from bulk-cultured B cells, while recombinant monoclonal antibodies (re-mAbs) were produced from single plasmablasts. The frequency of vaccine-specific plasmablasts and the concentration of PPAbs were lower in the elderly than in young adults, whereas the yields of secreted IgG per plasmablast were not different. Differences were not detected in the overall vaccine-specific avidity or affinity of PPAbs and re-mAbs between the 2 age groups. In contrast, reactivity of the antibodies induced by the inactivated seasonal influenza vaccine toward the 2009 pandemic H1N1 virus, which was not present in the vaccine, was higher in the elderly than in the young. These results indicate that the inferior antibody response to influenza vaccination in the elderly is primarily due to reduced quantities of vaccine-specific antibodies. They also suggest that exposure history affects the cross-reactivity of vaccination-induced antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci57834

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
A class of distributions which includes the normal ones
Azzalini, A. (1985) · Padua Research Archive (University of Padova) · Cited by 2,612
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,088
Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260

Show all 52 references

Research works printed but not linked: 4

Fiore, 2007, MMWR Recomm Rep., 56, 1
Gerhard, 2001, Curr Top Microbiol Immunol., 260, 171
Azzalini, 1985, Scand J Statist., 12, 171
Holm, 1979, Scand J Statist., 6, 65

Sorted by citations

Items 201–300 of 312

Enduring Challenge of Latent Tuberculosis in Older Nursing Home Residents: A Brief Review
Khan, A. H., Rebhan, A., Seminara, D., & Szerszen, A. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3763 · Cited by 12
Effect of Cytomegalovirus on the Immune System: Implications for Aging and Mental Health
Ford, B. N., & Savitz, J. B. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_376 · Cited by 12
Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
Bhatnagar, N., Kim, K., Subbiah, J., Muhammad-Worsham, S., Park, B. R., Liu, R., Grovenstein, P. B., Wang, B., & Kang, S. (2023) · Vaccines · doi:10.3390/vaccines11071209 · Cited by 11
Pre‐vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination
Çevirgel, A., Shetty, S. A., Vos, M. W., Nanlohy, N. M., Beckers, L., Bijvank, E., Rots, N. Y., van Beek, J., Buisman, A., & van Baarle, D. (2023) · Aging Cell · doi:10.1111/acel.14048 · Cited by 9
Influenza vaccination for older adults
Talbot, H. K., Libster, R., & Edwards, K. M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.8.1.18129 · Cited by 11
Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice
Raha, J. R., Kim, K., Bhatnagar, N., Liu, R., Le, C. T. T., Park, B. R., Grovenstein, P. B., Pal, S. S., Ko, E., Shin, C. H., et al. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105877 · Cited by 10
Structure and applications of novel influenza HA tri-stalk protein for evaluation of HA stem-specific immunity
Lu, I., Kirsteina, A., Farinelle, S., Willième, S., Tārs, K., Muller, C. P., & Kazāks, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204776 · Cited by 10
Immunosenescence in neurocritical care
Inoue, S., Saito, M., & Kotani, J. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0333-5 · Cited by 10
Vaccine-Preventable Diseases in Older Adults
Al-Jabri, M., Rosero, C., & Saade, E. (2023) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.09.009 · Cited by 10
An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humans
Kang, K. S., Lee, N., Shin, M. S., Kim, S. D., Yu, Y., Mohanty, S., Belshe, R. B., Montgomery, R. R., Shaw, A. C., & Kang, I. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.022 · Cited by 10
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine
Nicoli, F., Mantelli, B., Gallerani, E., Telatin, V., Squarzon, L., Masiero, S., Gavioli, R., Palù, G., Barzon, L., & Caputo, A. (2022) · npj Vaccines · doi:10.1038/s41541-022-00458-0 · Cited by 10
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
Park, B. R., Bommireddy, R., Chung, D. H., Kim, K., Subbiah, J., Jung, Y., Bhatnagar, N., Pack, C. D., Ramachandiran, S., Reddy, S. J. C., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00344-w · Cited by 9
The Avalanche is Coming … And Just Now It's Starting to Snow
Aspinall, R., & Lang, P. O. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00165 · Cited by 9
A phase 1, randomized, observer blind, antigen and adjuvant dosage finding clinical trial to evaluate the safety and immunogenicity of an adjuvanted, trivalent subunit influenza vaccine in adults ≥ 65 years of age
Otten, G. R., Matassa, V., Ciarlet, M., & Leav, B. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.058 · Cited by 9
Impact of the Raising Immunizations Safely and Effectively (RISE) Program on Healthcare Worker Influenza Immunization Rates in Long Term Care Settings
Nace, D. A., Handler, S. M., Hoffman, E. L., & Perera, S. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.08.016 · Cited by 9
Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population
Matsushita, M., Takeuchi, S., Kumagai, N., Uehara, Y., Matsushita, C., Arise, K., Seo, H., & Awatani, T. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.024 · Cited by 9
Tailored Vaccines Targeting the Elderly Using Whole Inactivated Influenza Vaccines Bearing Cytokine Immunomodulators
Khan, T., Heffron, C. L., High, K. P., & Roberts, P. C. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0119 · Cited by 9
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older
Essink, B. J., Vermeulen, W., Andrade, C., de Rooij, R., Isakov, L., Casula, D., & Albano, F. R. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126791 · Cited by 8
Human Coronaviruses: Counteracting the Damage by Storm
Schoeman, D., & Fielding, B. C. (2021) · Viruses · doi:10.3390/v13081457 · Cited by 8
Multiple network-constrained regressions expand insights into influenza vaccination responses
Avey, S., Mohanty, S., Wilson, J. H., Zapata, H. J., Joshi, S. R., Siconolfi, B., Tsang, S. W., Shaw, A. C., & Kleinstein, S. H. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx260 · Cited by 10
Influenza – A new pathogen every year
Abreu, R. B., & Ross, T. M. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.08.011 · Cited by 8
Dietary supplementation with spray-dried animal plasma improves vaccine protection in aged mice
Miró, L., Rosell‐Cardona, C., Amat, C., Polo, J., Moretó, M., & Pérez‐Bosque, A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1050961 · Cited by 9
Trivalent inactivated subunit influenza vaccine Influvac®: 30-year experience of safety and immunogenicity
van de Witte, S. V., Nauta, J. J. P., Giezeman‐Smits, K. M., & de Voogd, J. M. (2012) · Trials in Vaccinology · doi:10.1016/j.trivac.2012.10.001 · Cited by 8
Vaccination choices for older people, looking beyond age specific approaches
Aspinall, R., & Lang, P. O. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1411197 · Cited by 7
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention
Caimi, B., Franzetti, M., Velleca, R., Lai, A., Gatti, A., Rossi, P. L., D'Orso, M. I., Pregliasco, F. E., Balotta, C., & Calicchio, G. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02884-0 · Cited by 7
Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study
Ajlan, A. A., Ali, T. Z., Aleid, H. A., AlMeshari, K. A., Devol, E. B., Alkaff, M. A., Fajji, L., Alali, A., Halabi, D., Althuwaidi, S., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07764-x · Cited by 7
Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor
Xiao, T., Wei, M., Guo, X., Zhang, Y., Wang, Z., Xia, X., Qi, X., Wang, L., Li, X., & Leng, S. X. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00364-6 · Cited by 7
Vaccine responses in ageing and chronic viral infection
Rees-Spear, C., & McCoy, L. E. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab007 · Cited by 8
Kinetics and Correlates of the Neutralizing Antibody Response to SARS-CoV-2Preprint
Vanshylla, K., Cristanziano, V. D., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., et al. (2021) · SSRN Electronic Journal · doi:10.1101/2021.01.26.428207 · Cited by 7
Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory
Portilho, A. I., Correa, V. A., Cirqueira, C. D. S., & Gaspari, E. D. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2107931 · Cited by 6
IgG antibody and TH1 immune responses to influenza vaccination negatively correlate with M-protein burden in monoclonal gammopathy of undetermined significance
Tete, S. M., Horst, G., Wilting, K. R., Klijn, M. A., Westra, J., de Haan, A., Huckriede, A. L. W., Kluin‐Nelemans, H. C., Sahota, S. S., Bijl, M., et al. (2013) · Hematology and Leukemia · doi:10.7243/2052-434x-1-3 · Cited by 6
Why Influenza Viruses Continue to Pose a Significant Threat to Aging and Aged Populations Worldwide
Lang, P. O. (2013) · Current Geriatrics Reports · doi:10.1007/s13670-013-0070-5 · Cited by 6
B Cell–Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging
Frasca, D., & Blomberg, B. B. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017020113 · Cited by 6
Strain specificities in influence of ageing on germinal centre reaction to inactivated influenza virus antigens in mice: Sex-based differences
Bufan, B., Arsenović-Ranin, N., Petrović, R., Zivkovic, I. P., Stoiljković, V., & Leposavić, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110857 · Cited by 6
Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine
Miller, C. N., Kemp, T. J., Abrahamsen, M. E., Isaacs‐Soriano, K. A., Dunham, K., Sirak, B. A., Pan, Y., Lazcano-Ponce, E. C., Salmerón, J., Pinto, L. A., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.07.069 · Cited by 6
Complex Autoantibody Responses Occur Following Moderate to Severe Traumatic Brain InjuryPreprint
Needham, E., Stoevesandt, O., Thelin, E. P., Zetterberg, H., Zanier, E. R., Nimer, F. A., Ashton, N. J., Outtrim, J. G., Newcombe, V., Mousa, H. S., et al. (2020) · medRxiv · doi:10.1101/2020.07.24.20161786 · Cited by 6
SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from the University Hospital in Krakow, Poland
Owsianka, I., Pac, A., Jachowicz-Matczak, E., Gutkowska, K., Szczuciński, W., Maziarz, B., Sochacka-Tatara, E., Heczko, P. B., Sydor, W., Żółtowska, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1071204 · Cited by 5
New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice
Gogoi, H., Mansouri, S., Katikaneni, D. S., & Jin, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01674 · Cited by 5
Alterung und Immunität
Wagner, U. G., & Krasselt, M. (2014) · Osteologie/Osteology · doi:10.1055/s-0037-1622017 · Cited by 5
Rational design of next-generation vaccine adjuvants: From molecular mechanisms to hybrid delivery platforms
Zhao, Y., Li, J., Chen, J., Yang, C., Tao, J., & Zhu, R. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2644737 · Cited by 5
Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population
Matsushita, M., Takeuchi, S., Kumagai, N., Morio, M., Matsushita, C., Arise, K., & Awatani, T. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.09.034 · Cited by 4
Aging of Human Haematopoietic Stem Cells
Garrick, D., Djeghloul, D., Kuranda, K., & Goodhardt, M. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1232-8_7 · Cited by 4
Human immunophenotyping via low-variance, low-bias, interpretive regression modeling of small, wide data sets: Application to aging and immune response to influenza vaccination
Holmes, T. H., & He, X.-S. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.05.004 · Cited by 4
Self-citation
Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses
Moysi, E., Paris, R., Grand, R. L., Koup, R. A., & Petrovas, C. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2045198 · Cited by 4
In-Depth Determination and Analysis of the Human Paired Heavy and Light Chain Antibody Repertoire
DeKosky, B. J. (2017) · Springer theses · doi:10.1007/978-3-319-58518-5_3 · Cited by 4
MODELING OF IMMUNOSENESCENCE WITH AGING IN SYSTEMIC LUPUS ERYTHEMATOSUS
Balık, Z., Bayındır, Y., & Batu, E. D. (2022) · Anti-Aging Eastern Europe · doi:10.56543/aaeeu.2022.1.2.03 · Cited by 4
Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness
Cao, L., Zhao, S., Lou, J., Zheng, H., Chan, R. W. Y., Chong, K. C., Chen, Z., Chan, P. K. S., Zee, B. C.-Y., & Wang, M. H. (2021) · Viruses · doi:10.3390/v13040619 · Cited by 4
Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus
Boukhvalova, M. S., Mortensen, E., Mbaye, A., McKay, J., & Blanco, J. C. G. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1766334 · Cited by 4
When estrogen deficiency meets immune responses induced by rabies vaccination
Qian, H., Zhang, J., Tian, L., Liu, L., Li, M., Jiang, Z., Lei, X., Zheng, W., Sun, P., & Zheng, X. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02726-24 · Cited by 3
A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults
D’Onofrio, V., Jacobs, B., Alhatemi, A., Gussem, S. D., Verstraete, M., Porrez, S., Willems, A., Boever, F. D., Waerlop, G., Leroux-Roels, G. G., et al. (2025) · Vaccines · doi:10.3390/vaccines13090922 · Cited by 3
Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design
Grewe, I., Zoran, T., & Addo, M. M. (2026) · Immunological Reviews · doi:10.1111/imr.70098 · Cited by 4
Human B Cell Senescence in Pulmonary Infections
Blomberg, B. B. (2012) · Open Longevity Science · doi:10.2174/1876326x01206010047 · Cited by 3
Decreased vaccine protection of egg-based influenza vaccine in the elderly and nonhemagglutinin-focused immunity
Gonzalez, K. J., & Strauch, E. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151732 · Cited by 3
COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
Faizan, U., Nair, L. G., Zerdan, M. B., Jaberi‐Douraki, M., Anwer, F., & Raza, S. (2023) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355231190497 · Cited by 3
Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice
Takagi, Y., Nishimura, T., Aktar, S., Katayama, D., Takashima, K., Kawakita, T., Sekiya, T., Shingai, M., Tanaka, H., Akita, H., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102784 · Cited by 2
Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV
Massanella, M., Karris, M., Pérez‐Santiago, J., Yek, C., Vitomirov, A., & Mehta, S. R. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001824 · Cited by 2
Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation
Frasca, D., & Bueno, V. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1444527 · Cited by 2
Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines
Zhang, X., Shi, H., & Ross, T. M. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00539-3 · Cited by 2
Understanding the Mechanisms of Immune System Aging: Immune System Cell Development and Antibody Repertoires
Shahaf, G. L., Hazanov, H., Averbuch, D., Amu, S., Ademokun, A., Wu, Y.-C. B., Dunn‐Walters, D. K., Chiodi, F., & Mehr, R. (2014) · International perspectives on aging · doi:10.1007/978-3-319-06650-9_4 · Cited by 2
Efficacité des vaccins antigrippes chez la personne âgée
Lang, P.-O., Govind, S., & Aspinall, R. (2012) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2012.03.001 · Cited by 2
Vaccine Development in Special Populations
Edwards, K. M., & Creech, C. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802302-0.00007-8 · Cited by 2
Impact of Diet and Lifestyle on Vaccine Efficacy in Adults Aged 55 and Older: A Review.
Hodges, R., & Lamotte, A. V. (2022) · PubMed · Cited by 2
The FluPRINT dataset: A multidimensional analysis of the influenza vaccine imprint on the immune systemPreprint
Tomić, A., Tomic, I., Dekker, C. L., Maecker, H. T., & Davis, M. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/564062 · Cited by 2
Self-citation
Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk
Dhruva, S. S. (2026) · Circulation · doi:10.1161/circulationaha.125.078657 · Cited by 2
Spaceflight-Associated Immune System Modifications
Jeandel, J., Fonte, C., Calcagno, G., Bonnefoy, J., Ghislin, S., Kaminski, S., & Frippiat, J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88880 · Cited by 1
Detection of HHV-5 HHV-6a HHV-6b and HHV-7 in the urine: potential use as a non-invasive diagnostic tool for immune profiling
Govind, S., Lang, P. O., Bürkle, A., Moreno‐Villanueva, M., Franceschi, C., Capri, M., Bernard, J., Weinberger, B., Grubeck-Loebenstein, B., Fiegl, S., et al. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00490-9 · Cited by 1
Aging restricts maturation of CXCL13+ T follicular helper cells in human immunity
Bracey, N. A., Beppler, C., Bilich, T., Long, A. H., Solà, E., Barak, A., Few-Cooper, T. J., Mohsin, A., Shankar, V., Mallajosyula, V. V. A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117423 · Cited by 1
Self-citation
Development of B-cell response during immunization with inactivated influenza vaccines "Grippol plus", "Sovigripp" and "Ultrix"
Shurygina, A.-P. S., Vasilyev, K., Анатольевна, В. Е., Ladygina, M. D., Zubkova, T. G., Бузицкая, Ж. В., Stukova, M., & Lioznov, D. A. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-dob-2609 · Cited by 1
Sex and the Aging Immune System
Gibson, D. C., & Bupp, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00059-2 · Cited by 1
B-Cell Immunology in Space
Fonte, C., & Frippiat, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-16996-1_15 · Cited by 1
Usando a imunologia de sistemas para entender os mecanismos moleculares de doenças e vacinas
Nakaya, H. I. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2019.tde-12112020-121932 · Cited by 1
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2Preprint
Klein, F., Vanshylla, K., Cristanziano, V. D., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-148929/v1 · Cited by 1
An RNA replicon vaccine encoding HA and NA prevents shedding of antigen-drifted 2009 pandemic H1N1 influenza virus in the pig modelPreprint
García-Nicolás, O., Butticaz, L., Avanthay, R., Ruggli, N., Summerfield, A., & Zimmer, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.01.685547 · Cited by 1
The CD 27+ memory B cells display changes in the gene expression pattern in elderly individuals
Báez, A., Álvarez‐Laderas, I., Piruat, J. I., Caballero‐Velázquez, T., Barbado, M. V., Millán‐Uclés, Á., Medrano, M., García‐Guerrero, E., Sánchez‐Abarca, L. I., & Pérez‐Simón, J. A. (2014) · Immunology · doi:10.1111/imm.12381
Effects of Ageing on the Vaccination Response
Weinberger, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-43365-3_5
The Role of the Bone Marrow for Adaptive Immunity in Old Age
Grubeck‐Loebenstein, B., & Pangrazzi, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_170
Analysis of the Use of Medical Institutions and Prescription Drugs for Pulmonary Tuberculosis in Geriatric Patients
Moon, S. J., Lee, Y. S., & Rhew, K. (2018) · Korean Journal of Clinical Pharmacy · doi:10.24304/kjcp.2018.28.2.95
Extensive age-dependent loss of antibody diversity in naturally short-lived turquoise killifishPreprint
Bradshaw, W. J., Poeschla, M., Placzek, A., Kean, S., & Valenzano, D. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.21.261248
Contributions to the evidence base for reducing the impact of influenza in primary care
Verhees, R. A. F. (2021) · doi:10.26481/dis.20211126rv
The Role of the Bone Marrow for Adaptive Immunity in Old Age
Grubeck‐Loebenstein, B., & Pangrazzi, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_170-1
Imunização parenteral e de mucosas com Vesículas de Membrana Externa de Neisseria meningitidis do sorogrupo C visando reatividade com sorogrupo W em camundongos
Portilho, A. I. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2021.tde-08122022-115959
Additional file 2 of Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor
Xiao, T., Wei, M., Guo, X., Zhang, Y., Wang, Z., Xia, X., Qi, X., Wang, L., Li, X., & Leng, S. X. (2023) · Figshare · doi:10.6084/m9.figshare.23797379
Additional file 1 of Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor
Xiao, T., Wei, M., Guo, X., Zhang, Y., Wang, Z., Xia, X., Qi, X., Wang, L., Li, X., & Leng, S. X. (2023) · Figshare · doi:10.6084/m9.figshare.23797376
Avaliação da resposta imunológica contra SARS-CoV-2 em grupos de risco vacinados com CoronaVac
de Medeiros, G. X. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-24042024-170719
ВОЗРАСТНЫЕ ИЗМЕНЕНИЯ В ИММУННОЙ СИСТЕМЕ ПРИ СТАРЕНИИ ОРГАНИЗМА
Movsisyan, M. R. (2024) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2024.37-43
Predicting influenza vaccine-elicited antibody responses with practical point systems
Shen, Y., Sung, M.-H., Ge, Y., Chen, Y., Carlock, M. A., Hanley, H. B., Jiang, S., Handel, A., & Ross, T. M. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127737
The Impact of Viral and Host Factors on the Influenza A Virus Transmission BottleneckPreprint
Krupinsky, K. C., Bendall, E. E., Zhu, Y., Stockwell, M. S., Nguyen, H. Q., Meece, J. K., Maldonado, Y., Ellingson, K., Lutrick, K., Asturias, E. J., et al. (2025) · medRxiv · doi:10.64898/2025.12.02.25341469
Additional file 1 of Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
Semelka, C., DeWitt, M. E., Blevins, M. W., Holbrook, B. C., Sanders, J. W., & Alexander‐Miller, M. A. (2024) · Figshare · doi:10.6084/m9.figshare.26561866
Additional file 1 of Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study
Ajlan, A. A., Ali, T. Z., Aleid, H., AlMeshari, K. A., DeVol, E., Alkaff, M. A., Fajji, L., Alali, A. E., Halabi, D., Althuwaidi, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21332699
Additional file 1 of Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine
Liwsrisakun, C., Pata, S., Laopajon, W., Takheaw, N., Chaiwong, W., Inchai, J., Pothirat, C., Bumroongkit, C., Deesomchok, A., Theerakittikul, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19862825
Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity
Kurokawa, R., Mtali, C. S., Daniel, I. J., Einarsdottir, T., Reda, O., Irie, N., Sakhor, W., Niimura, K., Takatori, M., Sugata, K., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013866 · Cited by 1
Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets
Zhang, X., Thomas, M. H., Lynch, A., Shi, H., & Ross, T. M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0339613
The impact of viral and host factors on the influenza A virus transmission bottleneck
Krupinsky, K. C., Bendall, E. E., Zhu, Y., Stockwell, M. S., Nguyen, H. Q., Meece, J. K., Maldonado, Y., Ellingson, K., Lutrick, K., Asturias, E. J., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014079
Non-propagating RNA virus-vectored HA/NA vaccine prevents shedding of antigen-drifted H1N1 influenza virus in pigs
García-Nicolás, O., Butticaz, L., Avanthay, R., Ruggli, N., Summerfield, A., & Zimmer, G. (2026) · npj Vaccines · doi:10.1038/s41541-026-01428-6
Évaluation de combinaisons de ligands de PRR et de particules biodégradables pour la vaccination muqueuse
Gutjahr, A. (2017) · theses.fr (ABES) · doi:10.70675/6561aecez86b2z475bzafabz2884c60cfd70
Effets de stress associés aux vols spatiaux sur le système du complément et les cellules dendritiques
Jeandel, J. (2019) · theses.fr (ABES) · doi:10.70675/ef224fafzdd92z415ezbe2ez1ee2a696f766
Influenza vaccine-specific CD4+ T cell responses are impaired in older adults
Saint-Charles, P., Hagen, M., Autaa, G., Bijvank, E., Beckers, L., van Beek, J., van Baarle, D., Weinberger, B., & Appay, V. (2026) · npj Vaccines · doi:10.1038/s41541-026-01437-5
Cloning and expression of natively paired antibody fragments from single B cells of immunized rhesus macaques
Malik, J., Fletcher, C. V., & Avedissian, S. N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1832934
Rescuing age-associated vaccine hyporesponsiveness in murine and nonhuman primate models with an immunostimulatory vaccine adjuvant
Maxwell, J., Joyner, J. A., Norton, J. E., Knapp, W., Wang, I., Swaminathan, G., Monslow, M. A., & Citron, M. P. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2689208
Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvant
Riley, D. V., Baracco, L., Das, S., Tenaglia, B. M., Speed, S., Dillen, C., Hayes, J., Veliz, S. D., Nijhuis, H., Sage, V. L., et al. (2026) · mSphere · doi:10.1128/msphere.00171-26

Authors: Sasaki, S., Sullivan, M., Narvaez, C. F., Holmes, T. H., Furman, D., Zheng, N.-Y., Nishtala, M., Wrammert, J., Smith, K., James, J. A., Dekker, C. L., Davis, M. M., Wilson, P. C., Greenberg, H. B., & He, X.-S.
Affiliations: Stanford Medicine (US)
University of Chicago (US)
Emory University (US)
Oklahoma Medical Research Foundation (US)
Stanford University (US)
ORCID: Holmes, Tyson H.
Furman, David
Zheng, Nai-Ying
Nishtala, Madhuri
Wrammert, Jens
James, Judith A.
Dekker, Cornelia L.
Davis, Mark M.
Wilson, Patrick C.
Greenberg, Harry B.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2011-08-01
Volume: 121
Issue: 8
Pages: 3109-3119
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci57834
PMC: PMC3148747
OpenAlex: W2105359173
Cited by: 300
References: 52
Citations by year: 2026: 14 · 2025: 13 · 2024: 8 · 2023: 21 · 2022: 18 · 2021: 33 · 2020: 15 · 2019: 26 · 2018: 15 · 2017: 22 · 2016: 18 · 2015: 20 · 2014: 19 · 2013: 27 · 2012: 25
FWCI: 18.32
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (AI090023, AI057266, AI057229, DK56339)
National Institute of Allergy and Infectious Diseases (AI 057229, AI057158, U19AI090023, U19AI090019, AI057266, HHSN266200500026C, AI090023, U54AI057158, U19AI057229, U19AI057266)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-56339, P30DK056339)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR053483)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: inactivated influenza vaccine, vaccine efficacy, older adults, plasmablasts, antibody avidity, antibody affinity, 2009 H1N1 pandemic, cross-reactivity, exposure history, B cells, monoclonal antibodies
MeSH terms: Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Antibodies, Antibodies, Monoclonal, Antibody Affinity, Enzyme-Linked Immunosorbent Assay, Humans, Immunoglobulin A, Immunoglobulin G, Influenza, Human, Influenza Vaccines, Plasma Cells, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks